Desomorphine
Desomorphine is a semi-synthetic opioid commercialized by Roche, with powerful, fast-acting effects, such as sedation and analgesia. It was first discovered and patented by a German team working for Knoll in 1920 but was not generally recognized. It was later synthesized in 1932 by Lyndon Frederick Small. Small also successfully patented it in 1934 in the United States. Desomorphine was used in Switzerland under the brand name Permonid and was described as having a fast onset and a short duration of action, with relatively little nausea compared to equivalent doses of morphine. Dose for dose it is eight to ten times more potent than morphine.
| Clinical data | |
|---|---|
| Trade names | Permonid |
| Other names | Desomorphine, krokodil, dihydrodesoxymorphine, Permonid |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.406 |
| Chemical and physical data | |
| Formula | C17H21NO2 |
| Molar mass | 271.360 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
| |
| (what is this?) (verify) | |
Desomorphine is a morphine analogue where the 6-hydroxyl group and the 7,8 double bond have been reduced. The traditional synthesis of desomorphine starts from α-chlorocodide, which is itself obtained by treating codeine with thionyl chloride. By catalytic reduction, α-chlorocodide gives dihydrodesoxycodeine, which yields desomorphine on demethylation.
A desomorphine product, usually based on codeine, has been developed as a recreational drug. This is typically highly impure. The scaly sores and necrosis that develop around the injection site has prompted the name krokodil (Russian for crocodile).